A detailed history of Roubaix Capital, LLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Roubaix Capital, LLC holds 237,747 shares of MRVI stock, worth $1.24 Million. This represents 1.3% of its overall portfolio holdings.

Number of Shares
237,747
Previous 436,218 45.5%
Holding current value
$1.24 Million
Previous $3.12 Million 36.76%
% of portfolio
1.3%
Previous 2.25%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$6.84 - $9.73 $1.36 Million - $1.93 Million
-198,471 Reduced 45.5%
237,747 $1.98 Million
Q2 2024

Aug 02, 2024

BUY
$6.87 - $11.34 $3 Million - $4.95 Million
436,218 New
436,218 $3.12 Million
Q2 2023

Jul 26, 2023

BUY
$12.09 - $15.0 $638,847 - $792,615
52,841 Added 28.93%
235,480 $2.93 Million
Q1 2023

May 09, 2023

BUY
$12.99 - $16.48 $2.37 Million - $3.01 Million
182,639 New
182,639 $2.56 Million

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $687M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Roubaix Capital, LLC Portfolio

Follow Roubaix Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roubaix Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Roubaix Capital, LLC with notifications on news.